Get started
Author

Kengo Yamawaki

Observed names: 健吾 山脇, 山脇 健吾
Institution: Kyowa Kirin (Japan)
ORCID: 0000-0001-8962-1783
Observed ORCID: 0000-0001-8962-1783
OpenAlex ID: A5002573440
R-spondin1 plays an essential role in ovarian development through positively regulating Wnt-4 signaling
2008 · Kazuma Tomizuka, Kaori Horikoshi, et al. · Human Molecular Genetics · 354
Bardoxolone methyl: drug development for diabetic kidney disease
2020 · Hironori Kanda, Kengo Yamawaki · Clinical and Experimental Nephrology · 93
PDF
Nrf2 activator for the treatment of kidney diseases
2018 · Kengo Yamawaki, Hironori Kanda, et al. · Toxicology and Applied Pharmacology · 62
PDF
The soluble form of BMPRIB is a novel therapeutic candidate for treating bone related disorders
2016 · Kengo Yamawaki, Yuichiro Kondo, et al. · Scientific Reports · 15
PDF
First Preclinical Report of the Efficacy and PD Results of KHK2823, a Non-Fucosylated Fully Human Monoclonal Antibody Against IL-3Rα
2015 · Tadakazu Akiyama, Shin-ichiro Takayanagi, et al. · Blood · 12
Estrogen‐inducible sFRP5 inhibits early B‐lymphopoiesis in vivo, but not during pregnancy
2015 · Takafumi Yokota, Kenji Oritani, et al. · European Journal of Immunology · 9
PDF
Adult-Specific Systemic Over-Expression Reveals Novel In Vivo Effects of the Soluble Forms of ActRIIA, ActRIIB and BMPRII
2013 · Kengo Yamawaki, Shinobu Ueda, et al. · PLoS ONE · 9
PDF
Effects of NRF2 polymorphisms on safety and efficacy of bardoxolone methyl: subanalysis of TSUBAKI study
2023 · Kazuaki Ikejiri, Takafumi Suzuki, et al. · Clinical and Experimental Nephrology · 5
PDF
AYAME Study: Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Bardoxolone Methyl in Diabetic Kidney Disease (DKD) Patients
2023 · Tadao Akizawa, Kengo Yamawaki, et al. · Journal of the American Society of Nephrology · 4
Identification of osteoblast stimulating factor 5 as a negative regulator in the B-lymphopoietic niche
2015 · Natsuko Fujita, Michiko Ichii, et al. · Experimental Hematology · 4
Challenges in kidney disease: therapeutic potential of bardoxolone methyl
2022 · Kengo Yamawaki · Folia Pharmacologica Japonica · 2
PDF
Blockade of the interaction between BMP9 and endoglin on erythroid progenitors promotes erythropoiesis in mice
2021 · Ayami Yamaguchi, Ikuo Hirano, et al. · Genes to Cells · 2
PDF
Challenges in diabetic kidney disease: therapeutic potential of bardoxolone methyl
2021 · Kengo Yamawaki · Proceedings for Annual Meeting of The Japanese Pharmacological Society
PDF
Osteoblast Stimulating Factor-5 Regulates B Lymphopoiesis Via Inhibiting Pre B Cell Proliferation
2014 · Natsuko Fujita, Kenji Oritani, et al. · Blood
SFRP5 Inhibits Early Stages Of B-Cell Differentiation and Modulates Estrogen-Related Changes In The Immune System
2013 · Takafumi Yokota, Kenji Oritani, et al. · Blood
A Novel Method for Construction of 3D-Tissue Structures using " Origami " Technique
2004 · Kengo Yamawaki, Masashige Shinkai, et al. · アジア・太平洋化学工学会議発表論文要旨集
3s2-am1 組織・臓器を作るための新しい戦略
2003 · 政重 新海, 健吾 山脇, et al. · 日本生物工学会大会講演要旨集
New method for rapid formation of tissue structure using Transglutaminase
2003 · 山脇 健吾, 新海 政重, et al. · 化学工学会　研究発表講演要旨集 化学工学会第36回秋季大会
Works count: 18
Citation count: 571
H-index: 7
I10-index: 5
Year
Topic
Type